Last edition
News about "Novo Holdings "
Novo Holdings Invests in Series A Launch Financing for Callio Therapeutics
The oversubscribed Series A financing was led by Frazier Life Sciences, with significant participation from Novo Holdings and other life sciences investors including Jeito Capital, Omega Funds, Norwest, ClavystBio, EDBI, Platanus, Pureos Bioventures and SEEDS Capital.
Novo Holdings | 04/03/2025 | By Aishwarya
Novo Holdings Completes Acquisition of Catalent
With the completion of the transaction, holders of Catalent common stock are entitled to receive USD 63.50 per share in cash, representing a premium of approximately 47.5 percent to the 60-day volume-weighted average price as of February 2, 2024.
Novo Holdings | 20/12/2024 | By Aishwarya | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy